Financials
- Market Capitalization 48.52 M
- Employee 8
- Founded 2018
- CEO N/A
- Website www.impactbiomedinc.com
- Headquarter Nevada, United States
- FIGI BBG01JFZG014
- Industry 药品制造—常规
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.33
市销率
995.81
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4085 | OSTX OS Therapies Incorporated Common Stock | 1.64 USD | -2.38% | +9.33% | +10.07% | +42.61% | 75.65 M USD | ||
| 4148 | EXOZ eXoZymes Inc. - Common Stock | 7.17 USD | -0.14% | +8.31% | +52.55% | -26.08% | 66.55 M USD | ||
| 4290 | SCLX Scilex Holding Company - Common Stock | 5.43 USD | -2.51% | -6.22% | -17.23% | -33.21% | 46.12 M USD | ||
| 4443 | MIRA MIRA Pharmaceuticals, Inc. - Common Stock | 0.75 USD | -2.60% | -3.85% | -11.76% | -45.26% | 31.52 M USD |